S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
Log in

NASDAQ:IOSP - Innospec Stock Price, Forecast & News

$106.08
+1.11 (+1.06 %)
(As of 01/20/2020 03:06 PM ET)
Today's Range
$104.50
Now: $106.08
$106.86
50-Day Range
$97.53
MA: $101.59
$106.08
52-Week Range
$65.43
Now: $106.08
$107.10
Volume103,396 shs
Average Volume87,131 shs
Market Capitalization$2.60 billion
P/E Ratio25.75
Dividend Yield0.98%
Beta1.27
Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals worldwide. It operates through four segments: Fuel Specialties, Performance Chemicals, Oilfield Services, and Octane Additives. The Fuel Specialties segment offers a range of specialty chemical products used as additives in various fuels. Its products are used in the operation of automotive, marine, and aviation engines; power station generators; and heating oil. Read More…

Industry, Sector and Symbol

Industry Chemicals & allied products
Sub-IndustrySpecialty Chemicals
SectorBasic Materials
Current SymbolNASDAQ:IOSP
CUSIP45768S10
Phone303-792-5554

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.48 billion
Cash Flow$6.90 per share
Book Value$33.80 per share

Profitability

Net Income$85 million

Miscellaneous

Employees2,000
Market Cap$2.60 billion
Next Earnings Date2/18/2020 (Estimated)
OptionableOptionable

Receive IOSP News and Ratings via Email

Sign-up to receive the latest news and ratings for IOSP and its competitors with MarketBeat's FREE daily newsletter.


Innospec (NASDAQ:IOSP) Frequently Asked Questions

What is Innospec's stock symbol?

Innospec trades on the NASDAQ under the ticker symbol "IOSP."

How often does Innospec pay dividends? What is the dividend yield for Innospec?

Innospec declared a Semi-Annual dividend on Tuesday, November 5th. Shareholders of record on Tuesday, November 19th will be paid a dividend of $0.52 per share on Wednesday, November 27th. The ex-dividend date is Monday, November 18th. This is an increase from Innospec's previous Semi-Annual dividend of $0.50. View Innospec's Dividend History.

How were Innospec's earnings last quarter?

Innospec Inc. (NASDAQ:IOSP) released its quarterly earnings results on Tuesday, November, 5th. The specialty chemicals company reported $1.40 EPS for the quarter, topping the consensus estimate of $1.25 by $0.15. The specialty chemicals company earned $371.90 million during the quarter, compared to analyst estimates of $367.65 million. Innospec had a net margin of 6.69% and a return on equity of 15.52%. The firm's quarterly revenue was up 2.4% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.20 EPS. View Innospec's Earnings History.

When is Innospec's next earnings date?

Innospec is scheduled to release their next quarterly earnings announcement on Tuesday, February 18th 2020. View Earnings Estimates for Innospec.

What price target have analysts set for IOSP?

1 brokers have issued 12-month price objectives for Innospec's shares. Their forecasts range from $95.00 to $95.00. On average, they expect Innospec's share price to reach $95.00 in the next year. This suggests that the stock has a possible downside of 10.4%. View Analyst Price Targets for Innospec.

What is the consensus analysts' recommendation for Innospec?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Innospec in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Innospec.

Has Innospec been receiving favorable news coverage?

News articles about IOSP stock have been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. The research firm ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Innospec earned a daily sentiment score of 1.7 on InfoTrie's scale. They also gave media stories about the specialty chemicals company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the near future. View News Stories for Innospec.

Are investors shorting Innospec?

Innospec saw a increase in short interest in the month of December. As of December 13th, there was short interest totalling 354,700 shares, an increase of 32.3% from the November 28th total of 268,200 shares. Based on an average daily trading volume, of 96,000 shares, the days-to-cover ratio is currently 3.7 days. Approximately 1.5% of the shares of the company are short sold. View Innospec's Current Options Chain.

Who are some of Innospec's key competitors?

What other stocks do shareholders of Innospec own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Innospec investors own include Intellia Therapeutics (NTLA), Las Vegas Sands (LVS), Altria Group (MO), Exxon Mobil (XOM), NVIDIA (NVDA), Franklin Resources (BEN), Colgate-Palmolive (CL), Eastman Chemical (EMN), Emerson Electric (EMR) and Invesco (IVZ).

Who are Innospec's key executives?

Innospec's management team includes the folowing people:
  • Mr. Patrick S. Williams, Pres, CEO & Director (Age 54)
  • Mr. Ian P. Cleminson, Exec. VP & CFO (Age 53)
  • Dr. Philip J. Boon, COO & Exec. VP (Age 60)
  • Dr. Ian M. McRobbie, Chief Technology Officer and Sr. VP of Research & Technology (Age 70)
  • Mr. Brian R. Watt, Sr. VP of Corp. Devel. & Investor Relations (Age 60)

Who are Innospec's major shareholders?

Innospec's stock is owned by a number of of institutional and retail investors. Top institutional investors include State of Alaska Department of Revenue (0.08%), Bowling Portfolio Management LLC (0.04%), Louisiana State Employees Retirement System (0.03%), Nisa Investment Advisors LLC (0.02%) and Diversified Trust Co (0.01%). Company insiders that own Innospec stock include Brian Watt, Catherine Hessner, David Earl Williams, Hugh Aldous, Ian Cleminson, Ian Malcolm Mcrobbie, Milton C Blackmore, Patrick Williams, Philip Curran and Philip John Boon. View Institutional Ownership Trends for Innospec.

Which institutional investors are selling Innospec stock?

IOSP stock was sold by a variety of institutional investors in the last quarter, including Louisiana State Employees Retirement System, State of Alaska Department of Revenue, Diversified Trust Co and Nisa Investment Advisors LLC. Company insiders that have sold Innospec company stock in the last year include Brian Watt, Catherine Hessner, Hugh Aldous, Ian Cleminson, Milton C Blackmore, Patrick Williams, Philip Curran and Philip John Boon. View Insider Buying and Selling for Innospec.

Which institutional investors are buying Innospec stock?

IOSP stock was purchased by a variety of institutional investors in the last quarter, including Bowling Portfolio Management LLC. View Insider Buying and Selling for Innospec.

How do I buy shares of Innospec?

Shares of IOSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Innospec's stock price today?

One share of IOSP stock can currently be purchased for approximately $106.08.

How big of a company is Innospec?

Innospec has a market capitalization of $2.60 billion and generates $1.48 billion in revenue each year. Innospec employs 2,000 workers across the globe.View Additional Information About Innospec.

What is Innospec's official website?

The official website for Innospec is http://www.innospecinc.com/.

How can I contact Innospec?

Innospec's mailing address is 8310 SOUTH VALLEY HIGHWAY SUITE 350, ENGLEWOOD CO, 80112. The specialty chemicals company can be reached via phone at 303-792-5554 or via email at [email protected]


MarketBeat Community Rating for Innospec (NASDAQ IOSP)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  255 (Vote Outperform)
Underperform Votes:  253 (Vote Underperform)
Total Votes:  508
MarketBeat's community ratings are surveys of what our community members think about Innospec and other stocks. Vote "Outperform" if you believe IOSP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IOSP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/20/2020 by MarketBeat.com Staff

Featured Article: 52-Week Highs and Lows

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel